Frontier Bio on Overcoming the Organ Shortage With 3D-Printed Human Tissue

3D printing has profoundly transformed the medical field, bringing significant changes to the way we think about healthcare. At the heart of this transformation, Frontier Bio is exploring the opportunities offered by 3D printing and tissue engineering to grow human tissue in the laboratory. This technology opens up personalized and innovative perspectives in the field of regenerative medicine, offering customized solutions for the creation of tissues, medical devices and treatments.

At the same time, the ever-increasing number of animal experiments is becoming a cause for concern, with over 190 million animals used worldwide, and results that are not always conclusive. Frontier Bio’s main objective is therefore to design artificial tissues to replace animal experiments and contribute to the preservation of human life. The aim of these tissues? To address the growing shortage of organs for transplantation. We recently interviewed Eric Bennett, CEO of Frontier Bio, to find out more about the company’s intentions and plans.

Frontier Bio is using 3D technologies to make human tissue

3DN: Could you introduce Frontier Bio and talk about your connection with additive manufacturing?

Frontier Bio is at the forefront of laboratory-grown human tissue engineering, with the ambition of revolutionizing regenerative medicine. Our mission is to develop alternative solutions for aging or failing organs and tissues, offering a sustainable answer to the shortage of organ transplants. Additive manufacturing is central to our research and product development efforts. We use advanced 3D printing technologies and self-assembly techniques to design lung microtissues, brain microtissues and blood vessels. In addition, 3D printing is used to create molds for biomaterials and for rapid prototyping of laboratory devices, illustrating our innovative approach to tissue engineering.